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Hepatitis B virus (HBV) infection is a public health 
problem; approximately two billion people have been 
exposed to HBV and more than 300 million are chroni-
cally infected with this virus (Grimm et al. 2011). HBV 
is the prototype member of the Hepadnaviridae, a family 
of hepatotropic DNA viruses. The virus has a 42 nm di-
ameter viral particle and an extremely compact partially 
double-stranded circular genome (Dane et al. 1970). 
HBV is classified into eight genotypes (A-H) based on 
inter-group divergence of the entire genomic nucleotide 
sequence (Kramvis et al. 2008). Recently, an additional 
HBV genotype (I) was proposed (Yu et al. 2010). 
HBV genotypes and subgenotypes have distinct geo-
graphical distributions and are associated with the sever-
ity of liver diseases in different populations. Genotype A 
is distributed globally and is the main genotype found in 
Europe, North America, Africa and India. Genotype D 
is mainly found in the Middle East and the Mediterrane-
an Basin. Genotype E was originally reported in Africa 
(Kramvis & Kew 2007), while genotype G was initially 
reported in Europe and North America (Stuyver et al. 
2000). HBV genotype F is found in Central and South 
America, particularly in indigenous populations in 
South America (Devesa & Pujol 2007, Alvarado-Mora 
et al. 2011). Genotype H is frequent in Central and North 
America (Arauz-Ruiz et al. 2002) and is very closely 
related to genotype F (Alvarado-Mora et al. 2011). Re-
cently, HBV genotype I was described in northwestern 
China, Vietnam and Laos (Yu et al. 2010).
The most frequent HBV genotypes in Asia are B and 
C. Genotype C is associated with more aggressive liver 
disease and poorer response to antiviral therapy com-
pared to genotype B (Chu et al. 2002). Genotype C is as-
sociated with hepatocellular carcinoma (HCC) in older 
patients (Yu et al. 2005), while genotype B is associated 
with HCC in younger people and with acute hepatitis B 
in adults (Ni et al. 2004).
Genotype C is classified into 10 subgenotypes that 
differ in their geographical distribution: C1 is found in 
Thailand, Vietnam and Myanmar (South Asia), C2 is 
found in Japan and China (Far East Asia), C3 is found 
in New Caledonia and Polynesia, C4 is found in Austral-
ian Aborigines and C5 is confined to the Philippines and 
Vietnam (Ni et al. 2004, Chan et al. 2005, Kramvis et 
al. 2008). The subgenotypes C3-C10 are also found in 
Indonesia (Mulyanto et al. 2009, 2010). 
The most common genotype in Brazil is genotype 
A, followed by genotypes D and F. The North, North-
east and Southeast Regions have a higher frequency of 
genotype A, while genotype D is the most frequent in 
the South Region (Mello et al. 2007). In some regions, 
genotypes B and C are also detected at low prevalences, 
reflecting the presence of Asian descendants within the 
populations of these regions (Sitnik et al. 2004). The aim 
of this study was to determine the complete genome se-
quence of an HBV subgenotype C2 isolate from a native 
Brazilian patient and to infer the origin of this virus. 
The patient was a 54-year-old Caucasian female who 
was born in state of São Paulo (SP), Brazil. She was un-
employed at the time of the study (but worked in Ota, 
Gunma, Japan, from 2000-2009) and had been diag-
nosed with chronic hepatitis B in Japan, at which time 
antiviral treatment was started. No other comorbidities 
or relevant data on her clinical history were reported 
and her physical examination was normal. At that time, 
she had the following clinical assay results: aspartate 
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transaminase (AST) 73 IU/mL, alanine transaminase 
(ALT) 93 IU/mL, HBsAg (+), HBeAg (+) and anti-HBc 
(+). She received lamivudine 150 mg/day from August 
2005-October 2008. As HBV DNA was always detect-
ed, the treatment was changed to adefovir 10 mg/day. 
At that point, her clinical assay results were as follows: 
anti-HCV (-), anti-HIV (-), HBeAg (+), AST 37 IU/mL, 
ALT 32 IU/mL, HBV DNA 13,900,000 IU/mL (log 6.14) 
and genotype C; no resistance-related mutations were 
found in the DNA polymerase coding region. We started 
lamivudine plus tenofovir in June 2010 and HBV DNA 
became undetectable in September 2010. All procedures 
followed were in accordance with the ethical standards. 
The sample collected when the patient arrived in Bra-
zil was processed to amplify the complete HBV genome. 
HBV DNA extraction was conducted from 100 μL of 
serum using the acid guanidinium thiocyanate/phenol/
chloroform method (Chomczynski & Sacchi 1987). Am-
plification of the whole HBV genome was performed 
with the P1 and P2 primers described previously, with 
slight modifications (Gunther et al. 1995). The sample 
was submitted to DNA amplification by polymerase 
chain reaction (PCR) (Gomes-Gouvea 2005). 
Sequencing was performed in an ABI Prism® 3100 
Automatic Sequencer (Applied Biosystems, Foster City, 
CA, USA) (Sanger et al. 1977) using dideoxy nucleoside 
triphosphates containing fluorescent markers (Big Dye® 
Terminator v3.1 Cycle Sequencing Ready Reaction kit, Ap-
plied Biosystems, Foster City, CA, USA). For sequencing, 
we used 18 primers internal to the PCR fragment, generat-
ing sequences around 300-500 bp in length. The primers 
were as follows: PS3076F (Stuyver et al. 2000), RHBS2 
(Sitnik et al. 2004), P1.2, P2.2 (Gunther et al. 1995), 582R, 
LAM1F, 2817R, P184, P192, P194, P197, P1193R, P970F, 
2029R, X1577F (Gomes-Gouvea 2005), EP2.2. (Takahashi 
et al. 1995), PS3216R (Norder et al. 1994) and 5LAM5 (Da 
Silva et al. 2000). The quality of each electropherogram 
was evaluated using Phred-Phrap software (Ewing et al. 
1998) and consensus sequences were obtained by align-
ment of both sequenced strands using CAP3 software 
available from the Electropherogram quality analysis web 
page (asparagin.cenargen.embrapa.br/phph/).
The isolated complete genome was aligned with oth-
er previously reported complete genome sequences (n 
= 192) using ClustalX software (Thompson et al. 1997) 
and was edited with the SE-AL software (available from: 
tree.bio.ed.ac.uk/software/seal/). The Bayesian Markov 
chain Monte Carlo simulation implemented in BEAST 
v.1.4.8 (Drummond & Rambaut 2007) was applied to 
obtain the best possible estimates using both the relaxed 
uncorrelated lognormal and exponential molecular clock 
models and using the model of nucleotide substitution 
(general time-reversible + gamma + proportion invari-
ant). The molecular clock that best fits the data was 
chosen by Bayes factor comparison. After 10 million 
generations, the maximum clade credibility (MCC) tree 
was obtained by summarising 10,000 substitution trees 
and was then modified using a 10% burn-in using Tree 
Annotator v.1.5.3 (Drummond & Rambaut 2007). Phy-
logenetic trees were visualised and midpoint rooted in 
FigTree v1.2.2 (tree.bio.ed.ac.uk/software/figtree/).
The complete HBV genome was successfully ampli-
fied. The sequence was analysed for all reported mu-
tations of antiviral resistance and it did not show any 
mutation-related response. In addition, the patient har-
boured a virus with a precore mutation at position 1896 
(G-A), but no mutation at position 1899; this patient’s 
virus also lacked basal core promoter mutations. Once 
the MCC tree was obtained, the Brazilian isolate se-
quence grouped within genotype C, subgenotype HBV/
C2, along with four other sequences from China (Fig-
ure). This cluster was supported by an a posteriori prob-
ability of approximately 0.83. Sequence was deposited in 
GenBank under the accession HQ622095.
In Brazil, there is a highly miscegenated population 
and the HBV genotype distribution pattern in Brazil is 
different from that of other Latin American countries, 
with genotypes A, D and F being the most prevalent 
among HBV carriers in Brazil (Devesa & Pujol 2007, 
Mello et al. 2007, Santos et al. 2010). In the Southeast 
and South Regions, other HBV genotypes have been 
found that reflect the migrant origin of the population. 
In a previous study performed with chronic HBV car-
riers from different Brazilian regions, it was reported 
that genotype C was found in 13.2% of the patients, all 
of whom had an Asian background (Sitnik et al. 2004). 
In another study in Campinas, SP, the presence of the 
genotype C (3%) was reported in two Asian descendents 
and also in two Caucasians (Tonetto et al. 2009). In the 
Brazilian Amazon Region, one case of genotype C was 
reported among 44 patients (de Oliveira et al. 2008). Fi-
nally, in another study carried out in the states of Rio de 
Janeiro and Mato Grosso, Brazil, one case of genotype 
C was found (Bottecchia et al. 2008). In conclusion, the 
presence of genotype C in the Brazilian population is 
very low and most cases are restricted to the Asian popu-
lation living in the country or to those individuals with 
some contact with Asian people. In addition, because 
only a short HBV genome region was amplified in each 
of these previous studies, it is not possible infer the spe-
cific origin of each sequence. 
HBV infection is highly prevalent in China. A pre-
vious study verified that genotypes B and C are the 
predominant genotypes in China (Zhu & Dong 2009). 
The two major subgenotypes of genotype C HBV are 
subgenotype C1 (predominant in Southeast Asia) and C2 
(predominant in East Asia). In an interesting study, it 
was reported that in China the frequency of HBV geno-
type B tends to decrease gradually and that the preva-
lence of genotype C increases with increasing latitude 
(Zhu & Dong 2009). Furthermore, genotype C prevails 
in the northern provinces of China, while genotype B 
is more prevalent in southern China (Zeng et al. 2005). 
Likewise, there are significant differences in geographi-
cal distribution among the patients with genotypes B 
and C in Japan (Orito et al. 2001).
The complete HBV genome reported in this study 
grouped with other sequences from China. Based on the 
demographic and clinical information for this patient, we 
inferred that she may have acquired the infection during 
the period that she lived in Japan (9 years), although the 
origin of this sequence does not appear to be Japan. The 
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patient did not report any other information about the 
possible mode of transmission that could have aided us 
in making more inferences about this case. Phylogenetic 
analysis showed that within the group of genotype C2, 
the sequences previously reported from different coun-
tries (China, Japan, Korea, Taiwan, Thailand, Uzbeki-
stan) are interspersed. The sequence from this Brazil-
ian case grouped with four other sequences described in 
China, raising the possibility that someone who had di-
rect or indirect contact with people living in China might 
have infected our patient. It was not possible to determine 
the specific region of China from which this sequence 
could have originated because there is no specific publi-
cation about these sequences and we could not determine 
from which county these sequences were collected. The 
sequence of our patient is the first complete genome se-
quence of HBV subgenotype C2 reported in Brazil and it 
is noteworthy that this patient was not of Asian descent.
In conclusion, our results increase the understanding 
of the dynamics of HBV and demonstrate the applica-
tion of the Bayesian inference to determine the origin 
of an infection. We hypothesise that the native Brazil-
ian patient was infected with an HBV/C2 strain that is 
prevalent in China when she lived in Japan. 
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